- Home
- NFGC vs ANGO Comparison
NFGC vs ANGO Comparison
Compare NFGC & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NFGC
- ANGO
- Stock Information
- Founded
- NFGC 2016
- ANGO 1988
- Country
- NFGC Canada
- ANGO United States
- Employees
- NFGC N/A
- ANGO N/A
- Industry
- NFGC Precious Metals
- ANGO Medical/Dental Instruments
- Sector
- NFGC Basic Materials
- ANGO Health Care
- Exchange
- NFGC Nasdaq
- ANGO Nasdaq
- Market Cap
- NFGC 346.1M
- ANGO 401.4M
- IPO Year
- NFGC N/A
- ANGO 2004
- Fundamental
- Price
- NFGC $1.19
- ANGO $9.50
- Analyst Decision
- NFGC Strong Buy
- ANGO Strong Buy
- Analyst Count
- NFGC 1
- ANGO 3
- Target Price
- NFGC $5.00
- ANGO $13.00
- AVG Volume (30 Days)
- NFGC 1.3M
- ANGO 491.7K
- Earning Date
- NFGC 03-21-2025
- ANGO 04-02-2025
- Dividend Yield
- NFGC N/A
- ANGO N/A
- EPS Growth
- NFGC N/A
- ANGO N/A
- EPS
- NFGC N/A
- ANGO N/A
- Revenue
- NFGC N/A
- ANGO $286,498,000.00
- Revenue This Year
- NFGC N/A
- ANGO N/A
- Revenue Next Year
- NFGC N/A
- ANGO $6.63
- P/E Ratio
- NFGC N/A
- ANGO N/A
- Revenue Growth
- NFGC N/A
- ANGO N/A
- 52 Week Low
- NFGC $0.96
- ANGO $5.47
- 52 Week High
- NFGC $4.15
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- NFGC 30.68
- ANGO 45.54
- Support Level
- NFGC $0.96
- ANGO $9.34
- Resistance Level
- NFGC $1.74
- ANGO $10.29
- Average True Range (ATR)
- NFGC 0.11
- ANGO 0.42
- MACD
- NFGC -0.07
- ANGO 0.09
- Stochastic Oscillator
- NFGC 24.21
- ANGO 60.89
About NFGC New Found Gold Corp
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.